Immunophenotyping Assessment in a COVID-19 Cohort
Public ClinicalTrials.gov record NCT04378777. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective Cohort Study to Assess Longitudinal Immune Responses in Hospitalized Patients With COVID-19 (DAIT-COVID-19-002)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This surveillance study will collect detailed clinical, laboratory, and radiographic data in coordination with biologic sampling of blood and respiratory secretions and viral shedding in nasal secretions in order to identify immunophenotypic and genomic features of COVID-19 -related susceptibility and/or progression. The aim: for the results obtained from this study to assist in generating hypotheses for effective host-directed therapeutic interventions, to help to prioritize proposals for such interventions, and/or optimize timing for administration of host-response directed therapeutics.
Study identification
- NCT ID
- NCT04378777
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 1,227 participants
Conditions and interventions
Conditions
Interventions
- Biological sample collection Procedure
- Data Collection: Clinical Care Assessments Procedure
Procedure
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2020
- Primary completion
- Mar 18, 2021
- Completion
- Apr 20, 2022
- Last update posted
- May 18, 2022
2020 – 2022
United States locations
- U.S. sites
- 17
- U.S. states
- 12
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Arizona (UA) College of Medicine - Tucson: UA Health Sciences Asthma and Airway Disease Research Center | Tucson | Arizona | 85724 | — |
| University of California, Los Angeles: Department of Medicine | Los Angeles | California | 90024 | — |
| University of California San Francisco School of Medicine | San Francisco | California | 94115 | — |
| Stanford Medicine: Sean N. Parker Center for Allergy & Asthma Research | Stanford | California | 94305 | — |
| Yale School of Medicine | New Haven | Connecticut | 06520 | — |
| University of Florida Health Gainesville | Gainesville | Florida | 32608 | — |
| University of Florida Health Jacksonville | Jacksonville | Florida | 32209 | — |
| University of South Florida Health Tampa | Tampa | Florida | 33606 | — |
| Emory University School of Medicine | Atlanta | Georgia | 30317 | — |
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | — |
| Icahn School of Medicine at Mount Sinai | New York | New York | 10029 | — |
| University Hospitals Case Medical Center | Cleveland | Ohio | 44106 | — |
| University of Oklahoma ,Oklahoma Health Sciences Center: Pulmonary/Critical Care, Department of Medicine | Oklahoma City | Oklahoma | 73126 | — |
| Oregon Health & Science University | Portland | Oregon | 97239 | — |
| Drexel University College of Medicine | Philadelphia | Pennsylvania | 19102 | — |
| University of Texas at Austin: UT Health Austin | Austin | Texas | 78712 | — |
| Baylor College of Medicine: Department of Medicine | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Coronavirus Disease 2019 (COVID-19) trials
Other public records listing Coronavirus Disease 2019 (COVID-19). Sorted by last update posted; newest first. Not a recommendation.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04378777, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 18, 2022 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04378777 live on ClinicalTrials.gov.